Disparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil's public and private healthcare systems

There were significant differences in the provision of trastuzumab between the public and private healthcare systems, adversely affecting clinical outcomes and patient survival. The current data highlight the pressing need to address equity in cancer treatment to improve prognosis for every patient.

Authors

Institutions

Publication Details

Journal
The Breast
Published
2025-02-13
DOI
https://doi.org/10.1016/j.breast.2025.104417
Citations
5
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
8.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Disparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil's public and private healthcare systems

Marina Diógenes Teixeira, Fabrício Palermo Brenelli, Luíz Henrique Gebrim, Felipe Zerwes et al.
5 citations
The Breast
Chronic Lymphocytic Leukemia Research
8.13
article

Disparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil's public and private healthcare systems

Marina Diógenes Teixeira, Fabrício Palermo Brenelli, Luíz Henrique Gebrim, Felipe Zerwes, Marcelo Antonini, Antônio Luiz Frasson, Francisco Pimentel Cavalcante, Rogério Fenile, Marcellus do Nascimento Moreira Ramos, André P. L. Mattar, Marcelo Madeira, Gil Facina, Odair Ferraro, Eduardo Camargo Millen, Juliana Monte Real, Romualdo Barroso‐Sousa, Denise Joffily Pereira da Costa Pinheiro, Luís Oliveira, Irineu Luiz Maia, Andressa Gonçalves Amorim
article en
5 citations

Abstract

There were significant differences in the provision of trastuzumab between the public and private healthcare systems, adversely affecting clinical outcomes and patient survival. The current data highlight the pressing need to address equity in cancer treatment to improve prognosis for every patient.

The BreastVol. 80
Universidade Estadual de Campinas (UNICAMP) (BR), Hospital Israelita Albert Einstein (BR), Faculdade Ruy Barbosa (BR), Beneficência Portuguesa de São Paulo (BR), Breast Center (CH), Women’s Health Care (US), Instituto Nacional de Câncer - INCA (BR), Hospital do Servidor Público Estadual (BR), Hospital São Paulo (BR), Hospital Geral de Fortaleza (BR), Pontifícia Universidade Católica do Rio Grande do Sul (BR), Universidade Federal de São Paulo (BR)
Partnerships for the goals
Openalex Percentile: Top 3%
Chronic Lymphocytic Leukemia Research
8.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.